A detailed history of American International Group, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 17,408 shares of HRMY stock, worth $522,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,408
Previous 17,563 0.88%
Holding current value
$522,240
Previous $567,000 3.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$29.93 - $35.06 $4,639 - $5,434
-155 Reduced 0.88%
17,408 $584,000
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $10,828 - $19,051
-564 Reduced 3.11%
17,563 $567,000
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $18,559 - $22,715
582 Added 3.32%
18,127 $594,000
Q2 2023

Aug 04, 2023

BUY
$30.5 - $37.4 $91,896 - $112,686
3,013 Added 20.73%
17,545 $617,000
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $1,170 - $2,048
38 Added 0.26%
14,532 $474,000
Q4 2022

Feb 10, 2023

SELL
$45.4 - $60.91 $5,221 - $7,004
-115 Reduced 0.79%
14,494 $798,000
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $26,834 - $35,377
638 Added 4.57%
14,609 $647,000
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $27,569 - $42,867
822 Added 6.25%
13,971 $681,000
Q1 2022

May 13, 2022

SELL
$33.14 - $51.13 $26,710 - $41,210
-806 Reduced 5.78%
13,149 $640,000
Q4 2021

Feb 11, 2022

BUY
$34.09 - $43.91 $58,668 - $75,569
1,721 Added 14.07%
13,955 $595,000
Q3 2021

Nov 12, 2021

SELL
$25.68 - $38.61 $7,472 - $11,235
-291 Reduced 2.32%
12,234 $469,000
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $231,173 - $297,783
8,905 Added 245.99%
12,525 $354,000
Q1 2021

May 07, 2021

BUY
$27.56 - $40.37 $275 - $403
10 Added 0.28%
3,620 $120,000
Q4 2020

Feb 12, 2021

BUY
$31.74 - $51.34 $114,581 - $185,337
3,610 New
3,610 $131,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.77B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.